In vitro and in vivo inhibitory effects of disodium cromoglycate on influenza virus infection

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 6, 2004, Pages 825-830

  Hidari, Kazuya I P J ^a   Tsujii, Eisaku ^b   Hiroi, Jun ^b   Mano, Eriko ^a   Miyatake, Akihiko ^c   Miyamoto, Daisei ^a   Suzuki, Takashi ^a   Suzuki, Yasuo ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

^c Miyatake Asthma Clinic   (Japan)

Author keywords

Anti influenza drug; Influenza virus infection; Sodium cromoglycate

Indexed keywords

CROMOGLYCATE DISODIUM; RIBAVIRIN; SIALIDASE; ZANAMIVIR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; ASTHMA; CONTROLLED STUDY; DEATH; DRUG EFFECT; DRUG POTENCY; DRUG SAFETY; DRUG STRUCTURE; ENZYME INHIBITION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; INFLUENZA; INFLUENZA VIRUS; INHIBITION KINETICS; MEMBRANE FUSION; MOUSE; NONHUMAN; RESPIRATORY TRACT INFECTION; VIRUS ADSORPTION; VIRUS INFECTION; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; COMPARATIVE STUDY; DOG; DOSE RESPONSE; GROWTH, DEVELOPMENT AND AGING; GUINEA PIG; HUMAN; INFLUENZA VIRUS A; INTRANASAL DRUG ADMINISTRATION; VIROLOGY;

ADMINISTRATION, INTRANASAL; ANIMALS; CELL LINE; CROMOLYN SODIUM; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GUINEA PIGS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C;

EID: 16644402323     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.825     Document Type: Article

References (30)

1. Cox J. S., Nature (London), 216, 1328-1329 (1967).
2. Altounyan R. E., Acta Allergol, 30, 65-86 (1975).
3. Eigen H., Reid J. J., Dahl R., Del Bufalo C., Fasano L., Gunella G., Sahlstrom K. K., Alanko K. L., Greenbaum J., Hagelund C. H., Shapiro G. G., Marques R. A., Bellia V., Bonsignore G., Resta O., Foschino M. P., Carnimeo N., Granstorm S. A., Herrman F., Kjaerulff J., Nuchel-Pederson B., McDonald G. F., Sher N., Sheffer A. L., J. Allergy Clinic. Immunol., 80, 612-621 (1987).
4. Bissonette E. Y., Befus A. D., "Immunopharamacology of the Gastrointestinal System," Academic Press, London, 1993, pp. 95-103.
5. Mazurek N., Berger G., Pecht I., Nature (London), 286, 722-723 (1980).
6. Lavin N., Rachelefsky G. S., Kaplan S. A., J. Allergy Clinic. Immunol., 57, 80-88 (1976).
7. Staunton D. E., Merluzzi V. J., Rothlein R., Barton R., Marlin S. D., Springer T. A., Cell, 56, 849-853 (1989).
8. Hoshino M., Nakamura Y., Eur. Respir. J., 10, 858-865 (1997).
9. Penttinen K., Aarnio A., Hovi T., BMJ, 1, 82 (1977).
10. Aberg N., Aberg B., Alestig K., Clinic. Exp. Allergy, 26, 1045-1050 (1996).
11. Loveday D. E, Wenham R. B., BMJ, 2, 557-558 (1977).
12. Butler C. C., Robling M., Prout H., Hood K., Kinnersley P., Lancet, 359, 2153-2158 (2002).
13. Nagai T., Miyaichi Y., Tomimori T., Suzuki Y., Yamada H., Antiviral Res., 19, 207-217 (1992).
14. Suzuki Y., Matsunaga M., Matsumoto M., J. Biol. Chem., 260, 1362-1365 (1985).
15. Suzuki Y., Nagao Y., Kato H., Matsumoto M., Nerome K., Nakajima K., Nobusawa E., J. Biol. Chem., 261, 17057-17061 (1986).
16. Watanabe W., Sudo K., Asawa S., Konno K., Yokota T., Shigeta S., J. Virol. Methods, 51, 185-191(1995).
17. Guo C. T., Sun X. L., Kanie O., Shortridge K. F., Suzuki T., Miyamoto D., Hidari K. I. P. J., Wong C. H., Suzuki Y., Glycobiology, 12, 183-190 (2002).
18. Suzuki Y., Suzuki T., Matsumoto M., J. Biochem. (Tokyo), 93, 1621-1633 (1983).
19. MacDonald R. C., Dalle Ore V., MacDonald R. I., Virology, 134, 103-117 (1984).
20. Portner A., Scroggs R. A., Metzger D. W., Virology, 158, 61-68 (1987).
21. von Itzstein M., Wu W. Y., Kok G. B., Pegg M. S., Dyason J. C., Jin B., Van Phan J. T., Smythe M. L., White H. F., Oliver S. W., Colman P. M., Varghese J. N., Ryan D. M., Woods J. M., Bethell R. C., Hotham V. J., Cameron J. M., Penn C. R., Nature (London), 363, 418-423 (1993).
22. Mendel D. B., Tai C. Y., Escarpe P. A., Li W., Sidwell R. W., Huffman J. H., Sweet C., Jakeman K. J., Merson J., Lacy S. A., Lew W., Williams M. A., Zhang L., Chen M. S., Bischofberger N., Kim C. U., Antimicrob. Agents Chemother., 42, 640-646 (1998).
23. Sidwell R. W., Huffman J. H., Barnard D. L., Bailey K. W., Wong M. H., Morrison A., Syndergaard T., Kim C. U., Antiviral Res., 37, 107-120 (1998).
24. Weis W., Brown J. H., Cusack S., Paulson J. C., Skehel J. J., Wiley D. C., Nature (London), 333, 426-431 (1988).
25. Suzuki Y., Kato H., Naeve C. W., Webster R. G., J. Virol., 63, 4298-4302 (1989).
26. Suzuki Y., Nakao T., Ito T., Watanabe N., Toda Y., Xu G., Suzuki T., Kobayashi T., Kimura Y., Yamada A., Sugawara K., Nishimura H., Kitame F., Nakamura K., Deya E., Kiso M., Hasegawa A., Virology, 189, 121-131 (1992).
27. Suzuki Y., Prog. Lipid Res., 33, 429-457 (1994).
28. Wilson I. A., Skehel J. J., Wiley D. C., Nature (London), 289, 366-373 (1981).
29. White J. M., Science, 258, 917-924 (1992).
30. Isin B., Doruker P., Bahar I., Biophys. J., 82, 569-581 (2002).